Yves Dondelinger

3.7k total citations · 1 hit paper
21 papers, 2.7k citations indexed

About

Yves Dondelinger is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yves Dondelinger has authored 21 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Cancer Research. Recurrent topics in Yves Dondelinger's work include Cell death mechanisms and regulation (18 papers), NF-κB Signaling Pathways (12 papers) and interferon and immune responses (7 papers). Yves Dondelinger is often cited by papers focused on Cell death mechanisms and regulation (18 papers), NF-κB Signaling Pathways (12 papers) and interferon and immune responses (7 papers). Yves Dondelinger collaborates with scholars based in Belgium, United States and United Kingdom. Yves Dondelinger's co-authors include Mathieu J.M. Bertrand, Peter Vandenabeele, John Bertin, Peter J. Gough, Sasker Grootjans, Tom Delanghe, Inge Bruggeman, Paco Hulpiau, Ria Roelandt and Emmanuel Dejardin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Yves Dondelinger

21 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates

2014 663 citations Yves Dondelinger, Wim Declercq et al. Cell Reports profile →

Peers

Countries citing papers authored by Yves Dondelinger

Since Specialization

Citations

This map shows the geographic impact of Yves Dondelinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yves Dondelinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yves Dondelinger more than expected).

Fields of papers citing papers by Yves Dondelinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yves Dondelinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yves Dondelinger. The network helps show where Yves Dondelinger may publish in the future.

Co-authorship network of co-authors of Yves Dondelinger

This figure shows the co-authorship network connecting the top 25 collaborators of Yves Dondelinger. A scholar is included among the top collaborators of Yves Dondelinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yves Dondelinger. Yves Dondelinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NINJ1 is activated by cell swelling to regulate plasma membrane permeabilization during regulated necrosis 2023 ·Cell Death and Disease ·Yves Dondelinger, Dario Priem, (unknown), Tom Delanghe, Peter Vandenabeele, Mathieu J.M. Bertrand	36
2	The Impact of RIPK1 Kinase Inhibition on Atherogenesis: A Genetic and a Pharmacological Approach 2022 ·Biomedicines ·Pauline Puylaert, (unknown), (unknown), Yves Dondelinger, Tom Delanghe, Mathieu J.M. Bertrand, Pieter‐Jan Guns, Guido R.Y. De Meyer, Wim Martinet	5
3	Phosphorylation of RIPK1 serine 25 mediates IKK dependent control of extrinsic cell death in T cells 2022 ·Frontiers in Immunology ·(unknown), Yves Dondelinger, Alessandro Barbarulo, Mathieu J.M. Bertrand, Benedict Seddon	12
4	Antioxidant and food additive BHA prevents TNF cytotoxicity by acting as a direct RIPK1 inhibitor 2021 ·Cell Death and Disease ·Tom Delanghe, (unknown), (unknown), Dario Priem, Samya Van Coillie, Barbara Gilbert, Sze Men Choi, Peter Vandenabeele, Alexei Degterev, Gregory D. Cuny, Yves Dondelinger, Mathieu J.M. Bertrand	24
5	Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells 2020 ·American Journal of Respiratory and Critical Care Medicine ·Jennifer Simpson, Zhixuan Loh, Md Ashik Ullah, Jason P. Lynch, Rhiannon B. Werder, (unknown), Vivian Zhang, Yves Dondelinger, Mathieu J.M. Bertrand, Mark L. Everard, Christopher C. Blyth, Günter Härtel, Antoon J. van Oosterhout, Peter J. Gough, John Bertin, John W. Upham, Kirsten Spann, Simon Phipps	89
6	RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events 2020 ·Trends in Cell Biology ·Tom Delanghe, Yves Dondelinger, Mathieu J.M. Bertrand	108
7	Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation 2019 ·Nature Communications ·Yves Dondelinger, Tom Delanghe, Dario Priem, Meghan A. Wynosky-Dolfi, Daniel Sorobetea, Diego Rojas‐Rivera, Piero Giansanti, Ria Roelandt, (unknown), Klaus Ruckdeschel, Savvas N. Savvides, Albert J. R. Heck, Peter Vandenabeele, Igor E. Brodsky, Mathieu J.M. Bertrand	139
8	Monitoring RIPK1 Phosphorylation in the TNFR1 Signaling Complex 2018 ·Methods in molecular biology ·Dario Priem, Yves Dondelinger, Mathieu J.M. Bertrand	3
9	MK2 puts an additional brake on RIPK1 cytotoxic potential 2018 ·Cell Death and Differentiation ·Yves Dondelinger, Tom Delanghe, Mathieu J.M. Bertrand	10
10	N-glycosylation of mouse TRAIL-R restrains TRAIL-induced apoptosis 2018 ·Cell Death and Disease ·Yann Estornes, Yves Dondelinger, Kathrin Weber, Inge Bruggeman, (unknown), Marion MacFarlane, Serge Lebecque, Peter Vandenabeele, Mathieu J.M. Bertrand	15
11	MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death 2017 ·Nature Cell Biology ·Yves Dondelinger, Tom Delanghe, Diego Rojas‐Rivera, Dario Priem, Tinneke Delvaeye, Inge Bruggeman, Franky Van Herreweghe, Peter Vandenabeele, Mathieu J.M. Bertrand	162
12	Poly-ubiquitination in TNFR1-mediated necroptosis 2016 ·Cellular and Molecular Life Sciences ·Yves Dondelinger, Maurice Darding, Mathieu J.M. Bertrand, Henning Walczak	131
13	An evolutionary perspective on the necroptotic pathway 2016 ·Trends in Cell Biology ·Yves Dondelinger, Paco Hulpiau, Yvan Saeys, Mathieu J.M. Bertrand, Peter Vandenabeele	122
14	A real-time fluorometric method for the simultaneous detection of cell death type and rate 2016 ·Nature Protocols ·Sasker Grootjans, Behrouz Hassannia, Iris Delrue, Vera Goossens, Bartosz Wiernicki, Yves Dondelinger, Mathieu J.M. Bertrand, Dmitri V. Krysko, Marnik Vuylsteke, Peter Vandenabeele, Tom Vanden Berghe	50
15	CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3 2016 ·Nature Cell Biology ·Jinho Seo, Eun‐Woo Lee, (unknown), (unknown), Yves Dondelinger, Jihye Shin, Manhyung Jeong, Hae-Kyung Lee, Jung-Hoon Kim, Su Yeon Han, Cheolju Lee, Je Kyung Seong, Peter Vandenabeele, Jaewhan Song	153
16	NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling 2015 ·Molecular Cell ·Yves Dondelinger, Sandrine Jouan-Lanhouet, Tatyana Divert, Emilie Théâtre, John Bertin, Peter J. Gough, Piero Giansanti, Albert J. R. Heck, Emmanuel Dejardin, Peter Vandenabeele, Mathieu J.M. Bertrand	344
17	MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates breakdown → 2014 ·Cell Reports ·Yves Dondelinger, Wim Declercq, Sylvie Montessuit, Ria Roelandt, Amanda Gonçalves, Inge Bruggeman, Paco Hulpiau, Kathrin Weber, Clark A. Sehon, Robert W. Marquis, John Bertin, Peter J. Gough, Savvas N. Savvides, Jean‐Claude Martinou, Mathieu J.M. Bertrand, Peter Vandenabeele	663
18	Determination of apoptotic and necrotic cell death in vitro and in vivo 2013 ·Methods ·Tom Vanden Berghe, Sasker Grootjans, Vera Goossens, Yves Dondelinger, Dmitri V. Krysko, Nozomi Takahashi, Peter Vandenabeele	196
19	RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition 2013 ·Cell Death and Differentiation ·Yves Dondelinger, Miguel Aguileta, (unknown), (unknown), Sasker Grootjans, Emmanuel Dejardin, Peter Vandenabeele, Mathieu J.M. Bertrand	252
20	Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch between Necroptosis and RIPK1 Kinase-dependent Apoptosis 2012 ·Journal of Biological Chemistry ·Linde Duprez, Mathieu J.M. Bertrand, Tom Vanden Berghe, Yves Dondelinger, Nele Festjens, Peter Vandenabeele	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact